淋巴瘤
荧光原位杂交
医学
肿瘤科
疾病
阶段(地层学)
生发中心
癌症研究
化疗
内科学
威尼斯人
抗体
病理
B细胞
免疫学
生物
白血病
基因
慢性淋巴细胞白血病
染色体
古生物学
生物化学
作者
Eashwar Somasundaram,Jeremy S. Abramson
标识
DOI:10.1080/10428194.2024.2412295
摘要
hybridization (FISH) to demonstrate the rearrangements. DHL morphology ranges from DLBCL to high-grade B-cell lymphoma which can resemble Burkitt lymphoma and is almost always germinal center B-cell like (GCB). Prognosis is influenced by elevated lactate dehydrogenase (LDH), advanced stage, and extranodal involvement, among other factors. Treatment outcomes vary, but intensive chemotherapy regimens such as dose-adjusted EPOCH-R have shown the most promising results, though low-risk cases do occur and may do well with less intensive treatments. Recent therapeutic advances such as CAR-T cells and bispecific antibodies offer promise for patients with relapsed/refractory disease. This review synthesizes data from recent literature to provide a comprehensive analysis of the molecular underpinnings, diagnostic criteria, prognostic factors, and therapeutic strategies for DHL.
科研通智能强力驱动
Strongly Powered by AbleSci AI